Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Universal Health Services, Inc. (NYSE:UHS ) Q4 2024 Earnings Call February 27, 2025 10:00 AM ET Company Participants Steve Filton - Executive Vice President and Chief Financial Officer Marc Miller - Chief Executive Officer Conference Call Participants Andrew Mok - Barclays Ben Hendrix - RBC Capital Markets Ann Hynes - Mizuho Justin Lake - Wolfe Research Pito Chickering - Deutsche Bank Joanna Gajuk - Bank of America Stephen Baxter - Wells Fargo Sarah James - Cantor Fitzgerald AJ Rice - UBS Michael Ha - Baird Benjamin Rossi - JPMorgan Scott Fidel - Stephens Ryan Langston - TD Cowen Jamie Perse - Goldman Sachs Operator Good day and thank you for standing by. Welcome to the Fourth Quarter 2024 Universal Health Services Earnings Conference Call.
Although the revenue and EPS for Universal Health Services (UHS) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Universal Health Services (UHS) came out with quarterly earnings of $4.92 per share, beating the Zacks Consensus Estimate of $4.19 per share. This compares to earnings of $3.13 per share a year ago.
Beyond analysts' top -and-bottom-line estimates for Universal Health Services (UHS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.
Goldman Sachs downgraded Universal Health to Neutral from Buy with a price target of $198, down from $228. Amid rising policy uncertainty, with a wide range of potential outcomes, Goldman is taking a more cautious view on healthcare providers, the analyst tells investors in a research note. With this view, the firm downgraded hospitals Tenet (THC) and Universal Health (UHS) to Neutral while upgrading Lifestance Health Group (LFST) to Buy, where it believes the company is more insulated from policy risk. For Universal Health, the analyst sees policy risk "taking center stage" and likely leaving shares range bound until policy outcomes are better defined, reflected in out year estimates, and in the stock's valuation.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Universal Health Services, Inc. (NYSE:UHS ) Q3 2024 Earnings Conference Call October 25, 2024 9:00 AM ET Company Participants Steve Filton - Executive Vice President & Chief Financial Officer Conference Call Participants Marco Criscuolo - Nephron Research Ann Hynes - Mizuho Andrew Mok - Barclays A.J. Rice - UBS Pito Chickering - Deutsche Bank Joanna Gajuk - BofA Securities Jamie Perse - Goldman Sachs Ryan Langston - TD Cowen Matthew Gillmor - KBCM Whit Mayo - Leerink Partners Michael Ha - Baird Ben Hendrix - RBC Capital Markets Operator Good day, and thank you for standing by.
The headline numbers for Universal Health Services (UHS) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Universal Health Services (UHS) came out with quarterly earnings of $3.71 per share, missing the Zacks Consensus Estimate of $3.75 per share. This compares to earnings of $2.55 per share a year ago.